Key metrics and charts across all fundamental categories.
Stock price and market valuation
BAC trades at $57.91, a 38.8% increase year-over-year. Market capitalization stands at $420.20B, up 31.1% from the prior year. Track BAC price trends and market cap history to understand how the market values this company over time.
Revenue and earnings growth across quarters
$116.63B in TTM revenue grew 12.1% YoY, reaching $30.43B last quarter. TTM EBITDA of $-13.92B on operating income of $-3.96B shows growth is flowing through. Net income of $31.70B TTM confirms the company is converting revenue into profit. Revenue is growing at a healthy pace — a signal to hold.
Assets, cash, debt, and leverage
With $3.50T in assets and $325.96B in long-term debt, the D/E of 1.1 reflects moderate leverage — debt is manageable but worth monitoring.
Price multiples and return ratios
At 13.3x P/E, the stock trades below market averages — potentially undervalued. P/S of 3.6x and P/B of 1.4x provide additional context. Below-market P/E with growing revenue suggests a potential buying opportunity — the stock may be undervalued relative to its fundamentals.
Operating efficiency and return metrics
Op. margin of -13.0% is up 3.9% YoY — cost efficiency is improving. Net margin at 28.2% and gross margin of 42.1%. ROE of 10.5% shows the company generates solid returns on shareholder equity.
Free cash flow, earnings quality, and capital allocation
FCF of $41.77B on $41.77B in operating cash flow. The FCF / Net Income ratio of 1.3x means earnings are well backed by actual cash — high-quality earnings. Cash reserves of $242.48B provide financial flexibility. Shares outstanding declined 5.5% YoY — buybacks are returning capital to shareholders.
